Future-proofing in MedTech is not just about technology. It requires a shift in how products, business models, and healthcare systems are designed. This article explores how companies can adapt to digital transformation, rethink hardware, and reduce risk to stay competitive.

• Future-proofing requires more than upgrading technology
• Digital transformation remains a major challenge for MedTech companies
• Hardware is evolving into part of broader service ecosystems
• De-risking is central to long-term success in healthcare
Future-proofing in MedTech is about building products and businesses that can adapt to change.
It involves responding to evolving technologies, shifting patient needs, and new healthcare models.
At its core, it is about resilience.
Companies that succeed are not just reacting to change. They are actively preparing for it.
One of the biggest drivers of change in MedTech is digitalisation.
Remote monitoring, virtual care, and connected devices are reshaping how healthcare is delivered. At the same time, many companies struggle to adapt.
A Deloitte study showed that while most MedTech leaders see technology as their biggest challenge, very few consider themselves digitally mature.
“Companies are afraid to miss out, but don’t have the knowledge or the team to find their path to digitalisation. That’s why collaboration is so important.”
— Harm Hogenbirk
Medical devices remain at the core of healthcare.
But their role is changing.
Hardware is no longer the final product. It is part of a larger system that includes software, data, and services.
“Hardware is just an enabler for new business models — Platform as a Service, Software as a Service.”
— Harm Hogenbirk
This shift requires companies to think beyond individual devices and consider how their products fit into broader ecosystems.
Healthcare is moving toward prevention, home care, and improved quality of life. Devices must support these trends.
In healthcare, risk is always present.
Developing medical devices involves technical complexity, regulatory requirements, and direct impact on patient safety.
“In health, everything is about de-risking.”
— Harm Hogenbirk
De-risking means identifying and addressing potential issues early. It ensures that products meet regulatory standards, function reliably, and are safe in real-world use.
It also allows companies to adapt more effectively to changing market conditions.
Future-proofing is not a single decision. It is an ongoing process.
Companies need to:
- embrace digital transformation
- rethink the role of hardware
- build flexible and scalable business models
- integrate risk management into development
Those that succeed will not only keep up with change, but shape it.

Smart textiles are evolving into ultrawearables, garments that integrate sensing, computing, and intelligence directly into fabric. This shift is redefining how we interact with technology, while raising new technical and ethical challenges.

The Packaging and Packaging Waste Regulation introduces binding requirements for how packaging must be designed, labeled, and placed on the European Union market. This article explains PPWR in practical terms, refers to official regulatory sources, and outlines how Pilotfish integrates these requirements into real product development processes.
From concept to production, we help teams bring products to market faster - without compromising quality or compliance.
Because medical devices directly impact patient safety and must meet strict regulatory standards.
It is becoming part of larger ecosystems that include software and services.
Many companies lack the expertise and structure to implement it effectively.
It means designing products and strategies that can adapt to technological and market changes.